The Latest Breaking News from Vertex

Sarah O’Keeffe found out that her son would not be getting the medication that would improve his life

The market rally had a bullish reaction to the new Target warning. China EV giant BYD will supply batteries to Tesla.

Vertex Pharmaceuticals got an upgrade Wednesday on its burgeoning non-cystic fibrosis pipeline — as VRTX stock inched higher.

Drug stock Vertex is rounding out a new base and nearing a buy point as it continues to deliver solid earnings growth.

Analysts have provided the following ratings for Vertex (NASDAQ:VERX) within the last quarter:

"The lives of our children are being put at risk because of a financial dispute"

Multi-decade-high inflation and aggressive Fed rate increases might push the economy into a recession. So, investors looking to mitigate a market downturn should invest in Dollar Tree (DLTR) and Vertex Pharmaceuticals (VRTX), as they could deliver stable returns because their businesses enjoy a near-inelastic demand.

Vertex Energy Inc (NASDAQ:VTNR) reported first-quarter revenue growth of 60.6% year-over-year to $40.22 million, missing the consensus of $51.69 million. EPS loss was $(0.08) compared to $0.01 a year ago. The gross margin contracted by 466 bps to 3.8%. Vertex's operating loss increased to $(7.27) million from $(0.76) million a year ago.…

  Vertex (NASDAQ:VERX) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement.